CXCR7 Targeting and Its Major Disease Relevance

Area of Science:

• Pharmacology
• Molecular Biology
• Immunology

Background:

• Chemokine receptors are crucial in physiological and pathological processes.
• CXCR7 (ACKR3) is a non-classical seven-transmembrane receptor with debated signaling functions.
• Existing research on CXCR7 has limitations, including a narrow focus on ligands and insufficient data on ligand- and tissue-specific signaling.

Purpose of the Study:

• To review the endogenous and exogenous ligands of CXCR7.
• To summarize diseases associated with CXCR7.
• To discuss biased signaling events related to CXCR7.

Main Methods:

• Literature review focusing on CXCR7 ligands, associated diseases, and signaling.
• Analysis of existing research to identify sources of controversy.
• Synthesis of data to explain conflicting opinions on CXCR7 function.

Main Results:

• CXCR7 interacts with numerous natural ligands beyond SDF-1 and I-TAC.
• Ligand and tissue bias significantly influences CXCR7 signaling.
• Contradictory findings regarding CXCR7's signaling or scavenger role stem from these complexities.

Conclusions:

• The diverse ligand interactions and biased signaling of CXCR7 contribute to the ongoing debate about its function.
• Further research into CXCR7's pharmacologic properties is needed to clarify its role.
• This review highlights new directions for studying CXCR7 biology and pharmacology.